title: [Do the patients we treat with hypolipemic drugs have a coronary risk?].
abstract: OBJECTIVE
  To study the appropriateness of lipid-lowering drugs treatment through four methods of calculating coronary risk (CR).
  
  
  METHODS
  Crossover study.
  
  
  METHODS
  Primary care centre.
  
  
  METHODS
  All patients receiving lipid-lowering drugs.
  
  
  RESULTS
  CR was determined for individuals with application criteria by four methods: the simplified Framingham, Dundee-Risk-Disk, modified Sheffield label and Cardiovascular Risk in Primary Care (CVRap). 330 patients followed the treatment, 137 men and 193 women with an average age of 58.8 (SD 10.2). 54.2% received statims, 28.5% clofibrates, 13.6% resins and 3.6% other drugs. 186 patients were included, 75 (22.7%) being excluded because of secondary prevention and the rest because they were not the right age or had no cholesterol data prior to treatment. 38.3% were at high CR according to Framingham, 25.6% according to CVRap, 18.7% according to Dundee-Risk-Disk and 16% according to modified Sheffield. Concordance between these methods was adequate.
  
  
  CONCLUSIONS
  Between 16% and 38.3% of the individuals treated are at high CR. If we also include patients with severe Hypercholesterolaemia and diabetics with Hypercholesterolaemia, this percentage rises to 59.7-73.3%, according to the CR assessment method used.
authors.affiliation: Unidad Docente de MFyC, ABS Sant Josep, CAP Just Oliveras L' Hospitalet de Llobregat, Barcelona.
authors.forename: J
authors.initials: J
authors.lastname: Vilaseca Canais
authors.forename: C
authors.initials: C
authors.lastname: Buxeda Mestres
authors.forename: C
authors.initials: C
authors.lastname: Cámara Contreras
authors.forename: F
authors.initials: F
authors.lastname: Flor Serra
authors.forename: R
authors.initials: R
authors.lastname: Pérez Guinaldo
authors.forename: M
authors.initials: M
authors.lastname: Sánchez Viñas
mesh_terms: D000328:Adult; D000368:Aged; D003327:Coronary Disease / Q000453:epidemiology* / Q000209:etiology; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011320:Primary Health Care; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology
chemical_list: D000960:Hypolipidemic Agents